-
Posted by
Two Blokes Fri at 5:00 AM -
Filed in
Stock
-
2 views
Christophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the next five years, saying the U.S. market remain crucial for the Japanese drugmaker regardless of the global tariff tensions.
